These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33357087)

  • 1. Threshold dynamics of a HCV model with virus to cell transmission in both liver with CTL immune response and the extrahepatic tissue.
    Hu X; Li J; Feng X
    J Biol Dyn; 2021 Dec; 15(1):19-34. PubMed ID: 33357087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission.
    Guo T; Qiu ZP
    Math Biosci Eng; 2019 Jul; 16(6):6822-6841. PubMed ID: 31698590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of a diffusive-delayed HCV infection model with general cell-to-cell incidence function incorporating immune response and cell proliferation.
    Nangue A; Tchuimeni YJ
    Theory Biosci; 2023 Sep; 142(3):235-258. PubMed ID: 37436586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.
    Koziel MJ; Walker BD
    Springer Semin Immunopathol; 1997; 19(1):69-83. PubMed ID: 9266632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability analysis of general delayed HTLV-I dynamics model with mitosis and CTL immunity.
    Elaiw AM; Shflot AS; Hobiny AD
    Math Biosci Eng; 2022 Aug; 19(12):12693-12729. PubMed ID: 36654018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients.
    Rehermann B; Chang KM; McHutchinson J; Kokka R; Houghton M; Rice CM; Chisari FV
    J Virol; 1996 Oct; 70(10):7092-102. PubMed ID: 8794355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.
    Nelson DR; Marousis CG; Ohno T; Davis GL; Lau JY
    Hepatology; 1998 Jul; 28(1):225-30. PubMed ID: 9657116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.
    Nelson DR; Marousis CG; Davis GL; Rice CM; Wong J; Houghton M; Lau JY
    J Immunol; 1997 Feb; 158(3):1473-81. PubMed ID: 9013994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic analysis of a fractional-order delayed model for hepatitis B virus with CTL immune response.
    Shi R; Lu T; Wang C
    Virus Res; 2020 Feb; 277():197841. PubMed ID: 31887328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection.
    Freeman AJ; Pan Y; Harvey CE; Post JJ; Law MG; White PA; Rawlinson WD; Lloyd AR; Marinos G; Ffrench RA
    J Hepatol; 2003 Mar; 38(3):349-56. PubMed ID: 12586302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global stability analysis of humoral immunity virus dynamics model including latently infected cells.
    Elaiw AM
    J Biol Dyn; 2015; 9():215-28. PubMed ID: 26145479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global dynamics for discrete-time analog of viral infection model with nonlinear incidence and CTL immune response.
    Wang J; Teng Z; Miao H
    Adv Differ Equ; 2016; 2016(1):143. PubMed ID: 32226448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathogenesis of Liver Injury During Hepatitis C Virus Infection.
    Irshad M; Gupta P; Irshad K
    Viral Immunol; 2019 Apr; 32(3):112-120. PubMed ID: 30817236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local and global stability of an HCV viral dynamics model with two routes of infection and adaptive immunity.
    Sadki M; Harroudi S; Allali K
    Comput Methods Biomech Biomed Engin; 2024 Aug; 27(11):1510-1537. PubMed ID: 37599632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.
    Koziel MJ; Dudley D; Afdhal N; Choo QL; Houghton M; Ralston R; Walker BD
    J Virol; 1993 Dec; 67(12):7522-32. PubMed ID: 7693974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral infection dynamics with immune chemokines and CTL mobility modulated by the infected cell density.
    Shu H; Jin HY; Wang XS; Wu J
    J Math Biol; 2024 Mar; 88(4):43. PubMed ID: 38491217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global stability of secondary DENV infection models with non-specific and strain-specific CTLs.
    Raezah AA; Elaiw AM; Alshaikh MA
    Heliyon; 2024 Feb; 10(3):e25391. PubMed ID: 38352732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.
    Larrubia JR; Moreno-Cubero E; Miquel J; Sanz-de-Villalobos E
    World J Gastroenterol; 2015 Mar; 21(12):3480-91. PubMed ID: 25834312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global dynamics of multiple delays within-host model for a hepatitis B virus infection of hepatocytes with immune response and drug therapy.
    Yosyingyong P; Viriyapong R
    Math Biosci Eng; 2023 Feb; 20(4):7349-7386. PubMed ID: 37161155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
    Vertuani S; Bazzaro M; Gualandi G; Micheletti F; Marastoni M; Fortini C; Canella A; Marino M; Tomatis R; Traniello S; Gavioli R
    Eur J Immunol; 2002 Jan; 32(1):144-54. PubMed ID: 11754355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.